Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orlistat and SLx-4090 in Type 1 Hyperlipoproteinemia
NCT01675154Phase 2Terminated
- Sponsor
- UT Southwestern Medical Center
- Start
- Nov 2015
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of KD026 in familial lipoprotein lipase deficiency (LPLD), sponsored by UT Southwestern Medical Center. Started Nov 2015; status: terminated.
02
Drugs
KD026
03
Conditions
familial lipoprotein lipase deficiency (LPLD)
Beyond the preview
Go deeper on NCT01675154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01675154.